Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:23 PM
Ignite Modification Date:
2025-12-24 @ 12:23 PM
NCT ID:
NCT05887661
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of Hepatocellular Carcinoma
* Preference for laparoscopic hepatectomy and patient agreement
Exclusion Criteria:
* Age \<18 years
* Pregnancy
* Refusal of blood product transfusion
* Active cardiac conditions (unstable coronary syndromes, decompensated heart failure, significant arrhythmias, severe valvular disease, history of congestive heart failure)
* History of significant cerebrovascular disease
* Restrictive or obstructive pulmonary disease
* Uncontrolled hypertension
* Renal dysfunction (glomerular filtration rate \<60 mL/min),
* Hemoglobin \<100 g/L
* Abnormal coagulation values (international normalized ratio \>1.5 not on warfarin and/or platelet count \<100 ×109/L)
* Evidence of hepatic metabolic disorder (bilirubin \>35 mmol/L)
* Presence of active infection
* Preoperative autologous blood donation
* Patients were not allowed to receive erythropoietin at any time during the index hospitalization.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05887661
Study Brief:
Protocol Section:
NCT05887661